Current Trends of Yellow Fever in Nigeria: Challenges and Prospects

Authors

  • Abdulkadir B. Department of Microbiology Umaru Musa Yaradua University Katsina
  • Dazy D.B. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Abubakar M. A. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Farida A.T. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Samira I.G. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Aladelokun J. D. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Nafisat S. T. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Olaosebikan V. O. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Ibrahim E. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Ibrahim E. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Samira A. Department of Microbiology Kebbi State University of Science and Technology Aliero
  • Nwadigwe M. O. Department of Microbiology Kebbi State University of Science and Technology Aliero

DOI:

https://doi.org/10.47430/ujmr.1942.011

Keywords:

Yellow Fever,, Mosquito,, Outbreak,, Vaccine and Challenges.

Abstract

Yellow fever is a viral infection caused by yellow fever virus and is spread by the bite of an infected female mosquito (Aedes and Haemogogus species). The evolutionary origin of yellow fever lies in Africa, with transmission of the disease from nonhuman primates to human. Yellow fever remains a disease of significant public health importance. The earliest outbreak of yellow fever in Nigeria was reported in Lagos in 1864 with subsequent regular outbreaks reported until 1996 following which Nigeria has been responding to successive outbreaks. Since 15th September 2017, when the Nigeria Centre for Disease Control (NCDC) officially notified a confirmed case of yellow fever in Kwara state to WHO as per the International Health Regulations (2005). Currently the country has been responding to successive yellow fever outbreaks over a wide geographic area. As such, four-year (2018-2021) national yellow fever Preventive Mass Vaccination Campaign (PMVC) plan, supported by the Global Alliance for Vaccines and Immunization (GAVI) and partners, is currently being implemented to cover all states in the country. By 2025, it is anticipated that all states in Nigeria will have conducted PMVC activities to protect at-risk populations against yellow fever.

 

Downloads

Download data is not yet available.

References

Ankrah V, Nwaigwe F. (2005). Immunization system review and training needs assessment in Ekiti State. February. Ado - Ekiti Ministry of Health. PATHS.

Babalola S, Adewuyi A. (2005). Factors Influencing Immunization Uptake in Nigeria: A Theory-based Research in Six States. Abuja: PATHS.

Centre for Diseases Control (2016). Prevention of Yellow Fever. www.cdc. Retrieved 2019-10-26.

Dhiman, Gaurav; Ahruham, R, Griffin D. (2019) Human Schwann cells are susceptible to infection with zika and yellow fever viruses, but not dengue virus. Sciencetific reports. 9(1): 9951.

https://doi.org/10.1038/s41598-019-46389-0

Federal Bureau of Investigation. A Reviving routine immunization in Nigeria design team trip report. March, 2005

Feilden Battersby (2005). Analysts. Design of Routine Immunization Initiative-TripReport for DFID. Bath UK.

Fontenille D, Diallo M, Mondo M, Ndiaye M, Thonnon J (1997). "First evidence of natural vertical transmission of yellow fever virus in Aedes aegypti, its epidemic vector". Transactions of the Royal Society of Tropical Medicine and Hygiene. 91 (5): 533-5.

https://doi.org/10.1016/S0035-9203(97)90013-4

Hassan I. (2019). Another yellow fever outbreak kills 10 in Bauchi. Daily trust, Tuesday, November 5,2019.

Modrow, S.; et al. (2002). Molekulare Virologie - Eine Einführung für Biologen und Mediziner (2nd ed.). Spektrum Akademischer Verlag. p. 182.

Monath TP (April 2008). "Treatment of yellow fever". Antiviral Res. 78 (1): 116-24.

https://doi.org/10.1016/j.antiviral.2007.10.009

National Centre for Disease Control (2019): Situation Report of Cluster of Yellow Fever Outbreak in Bauchi State, Nigeria. www,ncdc.gov.ng

Obioha EE, Ajala AS, Matobo TA. (2010). Analysis of the performance of expanded programme on immunization (EPI) for four killer diseases under the military and civilian regimes in Nigeria, 1995-1999; 2000-2005. Ethno Med; 4(1): 43-52

https://doi.org/10.1080/09735070.2010.11886361

Oluwadare C (2009). The Social determinant of routine immunization in Ekiti State of Nigeria. Ethno-Med; 3(1): 49-56

https://doi.org/10.1080/09735070.2009.11886337

Oyewale Tomori (2002):Yellow Fever in Africa: Public Health Impact and Prospects for Control in the 21st Century. Biomédica, junio, año/vol. 22, número 002 Instituto Nacional de Salud(Colombia) Bogotá, Colombia pp. 178-193.

Rogers DJ, Wilson AJ, Hay SI, Graham AJ (2006). The global distribution of yellow fever and dengue. Advances in Parasitology. 62. pp. 181-220.

https://doi.org/10.1016/S0065-308X(05)62006-4

Silva .A. and patricia A.G.C. (2010). An RNA pseudoxnot is required for production of yellow fever virus. Subgenomic RNA by the host nuclease. Journal of virology. 84 (21): 11395-11406.

https://doi.org/10.1128/JVI.01047-10

Tolle MA (April 2009). "Mosquito-borne diseases". Curr Probl Pediatr Adolesc Health Care. 39 (4): 97-140.

https://doi.org/10.1016/j.cppeds.2009.01.001

Tomori O. (2002): yellow fever in Africa, public health impact and prospects for control in the 21st century. Biomedical. 22(2)(: 178-210.

World Health Organization (2013): yellow fever fact sheet N100gould Ea, DE LAMBALLERIERR x, Zanotto pm, Holmes (2003) origins, ovolution, coadaptations within the genus flavivirus. Advances in virus research 59. Pp. 222-314.

World Health Organization (2016). Yellow fever laboratory diagnostic testing in Africa. Interim guidance.

World Health Organization. (2019). Yellow fever - Nigeria. Disease outbreak news. 9th January, 2019.

Yola AW (2003). Report on Child Immunization Clusters (CICS); 4: 1-3.

Downloads

Published

30-12-2019

How to Cite

Abdulkadir B., Dazy D.B., Abubakar M. A., Farida A.T., Samira I.G., Aladelokun J. D., Nafisat S. T., Olaosebikan V. O., Ibrahim E., Ibrahim E., Samira A., & Nwadigwe M. O. (2019). Current Trends of Yellow Fever in Nigeria: Challenges and Prospects. UMYU Journal of Microbiology Research (UJMR), 4(2), 64–69. https://doi.org/10.47430/ujmr.1942.011

Issue

Vol. 4 No. 2 (2019): UMYU Journal of Microbiology Research (UJMR), Volume 4, Number 2, December 2019

Section

Articles

License

Copyright (c) 2023 UMYU Journal of Microbiology Research

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)